Ainhoa Vivero Larraza

High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial

Q. Bassat, B. Clotet, S. Marfil, 2022, The Lancet Respiratory Medicine.

Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients

Q. Bassat, B. Clotet, A. Troxel, 2022, Nature Communications.